As mentioned before, upregulation of ALKBH5 or IGF2BP2 were both significantly associated with poor survival in several studies, highlighting the prognostic value of ALKBH5 and IGF2BP2 in pancreatic cancer. The gene discussed is ALKBH5; the disease is pancreatic neoplasm.